Pulmonary surfactant, a complex mixture of phospholipids and specific
associated proteins, reduces the surface tension at the air-liquid int
erface of the distal conducting airways and gas exchanging alveoli of
the lung. Lipids, primarily neutral and phospholipids, compose approxi
mately 90% of the surfactant complex. The remaining 10% of surfactant
is composed of at least three surfactant-specific proteins, designated
surfactant protein A (SP-A), SP-B, and SP-C. These proteins contribut
e to the formation, stabilization, and function of organized surfactan
t structures. This article briefly reviews the normal composition and
function of pulmonary surfactant and specifically reviews the structur
e, function, and regulation of surfactant protein B (SP-B). The recent
identification of neonates with refractory respiratory failure due to
a genetic absence of SP-B and the study of transgenic mice in which S
P-B gene expression has been ablated highlight the importance of the p
rotein to surfactant function, synthesis, and metabolism and to the ma
intenance of lung function. Gene reconstitution experiments in vitro a
nd in SP-B-deficient transgenic mice suggest specific functions for th
e amino and carboxyl terminal domains of the protein. SP-B deficiency
is a potential target for gene therapy in human patients. (C) 1998 Aca
demic Press.